Cytochrome c oxidase is essential for copper-induced regression of cardiomyocyte hypertrophy

Xiao Zuo1, Huiqi Xie, Daoyin Dong

  • 1Regenerative Medicine Research Center and Laboratory of Stem Cell and Tissue Engineering, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.

Insights

Copper and vascular endothelial growth factor (VEGF) reduce cardiomyocyte hypertrophy by restoring cytochrome c oxidase (COX) activity. This study confirms COX is crucial for both copper and VEGF-mediated regression of enlarged heart cells.

Area of Science:

  • Cardiovascular Biology
  • Cellular Physiology

Background:

  • Hypertrophic cardiomyopathy is linked to reduced cytochrome c oxidase (COX) activity.
  • Copper (Cu) and vascular endothelial growth factor (VEGF) are known to reduce cardiomyocyte size, with Cu's effect being VEGF-dependent.

Purpose of the Study:

  • To investigate the role of COX as a key factor in copper-induced regression of cardiomyocyte hypertrophy.
  • To determine if COX activity mediates the effects of both copper and VEGF on hypertrophic cardiomyocytes.

Main Methods:

  • Induction of cardiomyocyte hypertrophy using phenylephrine (PE) in primary neonatal rat cardiomyocyte cultures.
  • Treatment with copper sulfate and/or VEGF, with and without COX inhibition via gene silencing (siRNA targeting COX-I).
  • Assessment of cell size, protein content, molecular markers, and COX activity.

Main Results:

  • PE-induced hypertrophy decreased COX activity; copper addition restored COX activity and reversed hypertrophy.
  • Gene silencing of COX-I inhibited COX activity and blocked copper-induced regression.
  • VEGF restored COX activity and induced regression, but this effect was blocked by COX inhibition.

Conclusions:

  • Cytochrome c oxidase (COX) activity is depressed in hypertrophic cardiomyocytes.
  • Both copper and VEGF restore COX activity, playing a determinant role in the regression of cardiomyocyte hypertrophy.
  • COX is a critical mediator for both copper- and VEGF-induced beneficial effects on hypertrophic heart cells.